These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6425458)

  • 21. Ustur whole body case 0269: demonstrating effectiveness of i.v. CA-DTPA for Pu.
    James AC; Sasser LB; Stuit DB; Glover SE; Carbaugh EH
    Radiat Prot Dosimetry; 2007; 127(1-4):449-55. PubMed ID: 18227077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An analysis of a puncture wound case with medical intervention.
    Bailey BR; Eckerman KF; Townsend LW
    Radiat Prot Dosimetry; 2003; 105(1-4):509-12. PubMed ID: 14527019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reducing the cancer risk of 239Pu by chelation therapy.
    Jones CW; Mays CW; Taylor GN; Lloyd RD; Packer SM
    Radiat Res; 1986 Sep; 107(3):296-306. PubMed ID: 3749464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The binding of plutonium to transferrin in the presence of tri-n-butyl phosphate or nitrate and its release by diethylenetriaminepenta-acetate and the tetrameric catechoylamide ligand LICAMC(C).
    Duffield JR; Taylor DM; Proctor SA
    Int J Nucl Med Biol; 1986; 12(6):483-7. PubMed ID: 3754852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The removal of zinc from the mouse by polyamincarboxylic acids (CDTA and DTPA) following semichronic zinc ingestion.
    Domingo JL; Llobet JM; Colomina MT; Corbella J
    Vet Hum Toxicol; 1988 Dec; 30(6):524-7. PubMed ID: 3149813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Derivation and validation of a urinary excretion function for plutonium based on occupational exposure.
    Yadav JR; Rao DD; Hegde AG; Aggarwal SK
    Radiat Prot Dosimetry; 2008; 129(4):386-90. PubMed ID: 17974581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modelling of bioassay data from a Pu wound treated by repeated DTPA perfusions: biokinetics and dosimetric approaches.
    Fritsch P; Grappin L; Guillermin AM; Fottorino R; Ruffin M; Mièle A
    Radiat Prot Dosimetry; 2007; 127(1-4):120-4. PubMed ID: 17562647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plutonium-DTPA Model Application with USTUR Case 0269.
    Konzen K; Brey R; Miller S
    Health Phys; 2016 Jan; 110(1):59-65. PubMed ID: 26606066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practical action levels for chelation therapy in plutonium inhalation using nose swab.
    Kurihara O; Takada C; Takasaki K; Ito K; Momose T; Miyabe K
    Radiat Prot Dosimetry; 2007; 127(1-4):411-4. PubMed ID: 17567761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic and therapeutic studies of plutonium. IV. ANL-7535.
    Lindenbaum A; Rosenthal MW; Lund CJ; Russell JJ; Smoler MH; Moretti ES; Brown H
    ANL Rep; 1968 Dec; ():60-5. PubMed ID: 5306872
    [No Abstract]   [Full Text] [Related]  

  • 31. Interpretation of Enhanced Fecal and Urinary Plutonium Excretion Data under a 2-y Regular DTPA Treatment Started Months after Intake.
    Grémy O; Blanchin N; Miccoli L
    Health Phys; 2021 Nov; 121(5):494-505. PubMed ID: 34591820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computer simulation of metal ion equilibria in biofluids. Part 3. Trace metal supplementation in total parenteral nutrition.
    Berthon G; Matuchansky C; May PM
    J Inorg Biochem; 1980 Aug; 13(1):63-73. PubMed ID: 6772743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical uses of metal-binding drugs.
    Chenoweth MB
    Clin Pharmacol Ther; 1968; 9(3):365-87. PubMed ID: 4984845
    [No Abstract]   [Full Text] [Related]  

  • 34. The importance of ligand speciation in environmental research: a case study.
    Sillanpää M; Orama M; Rämö J; Oikari A
    Sci Total Environ; 2001 Feb; 267(1-3):23-31. PubMed ID: 11286213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chelating agents in medicine.
    Williams DR; Halstead BW
    J Toxicol Clin Toxicol; 1982 Dec; 19(10):1081-115. PubMed ID: 6820958
    [No Abstract]   [Full Text] [Related]  

  • 36. Three plutonium chelation cases at Los Alamos National Laboratory.
    Bertelli L; Waters TL; Miller G; Gadd MS; Eaton MC; Guilmette RA
    Health Phys; 2010 Oct; 99(4):532-8. PubMed ID: 20838095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complexation of DTPA and EDTA with Cd
    Karak T; Paul RK; Das DK; Boruah RK
    Environ Monit Assess; 2016 Dec; 188(12):670. PubMed ID: 27848112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A comparative evaluation of the efficacy of different methods for the decorporation of plutonium from the respiratory organs].
    Liubchanskiĭ ER; Sokhranich AL; Sokol'nikov ME
    Radiats Biol Radioecol; 1997; 37(1):105-10. PubMed ID: 9102121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of DFO-HOPO, DTPA-DX and DTPA for enhancing the excretion of plutonium and ameriicum from the rat.
    Stradling GN; Gray SA; Moody JC; Hodgson A; Raymond KN; Durbin PW; Rodgers SJ; White DL; Turowski PN
    Int J Radiat Biol; 1991 May; 59(5):1269-77. PubMed ID: 1675243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and initial evaluation for in vivo chelation of Pu(IV) of a mixed octadentate spermine-based ligand containing 4-carbamoyl-3-hydroxy-1-methyl-2(1H)-pyridinone and 6-carbamoyl-1-hydroxy-2(1H)-pyridinone.
    Xu J; Durbin PW; Kullgren B; Ebbe SN; Uhlir LC; Raymond KN
    J Med Chem; 2002 Aug; 45(18):3963-71. PubMed ID: 12190318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.